Bradford C. Berk, MD
Advisory Board Member
Dr. Bradford Berk is a Distinguished University Professor in Medicine, Neurology, Pathology and Pharmacology and Physiology as well as the Director of the University of Rochester Medical Center’s Neurorestoration Institute (URNI). In 2015, Dr. Berk stepped down from his role as CEO of the University of Rochester Medical Center to lead this new initiative to make Rochester a national center for the rehabilitation of individuals with chronic neurologic diseases to improve their function and state of well-being. The mission of the URNI is to bring the highest quality and most innovative approaches to restore function in individuals who have suffered damage to their brain, spinal cord, and/or peripheral nerves with a vision of being nationally recognized as a leading center for rehabilitation focused on restoration of cognitive, motor, and sensory function. Having suffered a severe spinal cord injury in 2009, Dr. Berk’s story of recovery and perseverance has served as an inspiration to countless individuals who suffer from spinal cord injury. Dr. Berk’s perspective as a health care leader, physician, and a spinal cord injury patient has provided him with unique insight into the shortcomings and opportunities that exist in how we currently provide care and support to individuals (and their families) with chronic neurologic diseases.
Prior to 2015, Dr. Berk served as the Senior Vice President for Health Sciences at the University of Rochester and CEO of the University of Rochester Medical Center (URMC). Under his leadership, the Medical Center underwent a prodigious expansion through regional affiliations, acquisitions, and partnerships, as well as on-campus construction including the Golisano Children’s Hospital and the Wilmot Cancer Center. Dr. Berk oversaw the development of a number of initiatives, including the Clinical and Translational Science Institute, the Eastman Institute for Oral Health, and the Center for Experiential Learning, as well as nearly $1 billion in capital and information technology upgrades.
Since receiving his M.D. and Ph.D. degrees from the University of Rochester School of Medicine and Dentistry, Dr. Berk has served on the faculties of Harvard Medical School, Emory University, and the University of Washington. Prior to becoming CEO in 2006, Dr. Berk served as Chairman of Medicine and Chief of the Cardiology Unit at URMC. In addition, he founded and directed URMC’s Aab Cardiovascular Research Institute (CVRI).